Project Grant R01AG103064
- The National Institute on Aging awarded Northwestern University $1,341,808 on February 15, 2026, under the Aging Research program (CFDA 93.866) to conduct longitudinal research on aging-in-place and long-term care decision-making among older adults with Alzheimer's dementia. The research extends a current cohort study (R01AG058777) of 293 older adults with a 94.5 percent retention rate. Northwestern will follow subjects every six months through 42 months with surveys examining how aging-in-place...
- The National Institute on Aging awarded the University of California, Los Angeles $623,176 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct research on modifiable risk factors for Alzheimer's disease and related dementias among individuals aged 90 and older. The research triangulates evidence across four data sources—the LifeAfter90 Study (1,397 participants, all aged 90), the 90+ Study (1,630 participants, all aged 90), the Health and Retirement Study (3,359...
- The National Institute on Aging awarded The Johns Hopkins University $769,960 under the Aging Research program (CFDA 93.866) on September 1, 2026, for research examining how changes in home health care agency ownership and private capital investment affect access to care, quality of care, and patient outcomes for people living with dementia. The project, which runs through May 31, 2031, investigates the impact of multi-state chain acquisitions and private capital investments on home health...
- The National Institute on Aging awarded the University of Alabama at Birmingham $5,057,416 on September 15, 2025, under the Aging Research program (CFDA 93.866) to examine the impact of undiagnosed dementia on healthcare utilization across geographic regions. The recipient will augment Medicare claims data with cognitive assessment data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a longitudinal cohort of 30,239 participants from 1,833 counties across the...
- The University of California, Los Angeles received a $2.7 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded September 1, 2025, with completion scheduled for August 31, 2029. This research project will generate rigorous evidence comparing health outcomes for older patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) who are discharged from hospitals to home-based care versus facility-based...
- The National Institute on Aging awarded $1,887,004 to the National Opinion Research Center on September 15, 2025, under the Aging Research program (CFDA 93.866) to sustain and expand the Dementia DataHub surveillance infrastructure through April 30, 2030. The Dementia DataHub is an online, interactive visualization tool providing estimates of diagnosed Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) at national, state, and county levels. The award funds four primary...
- The National Institute on Aging, a component of the Department of Health and Human Services, awarded The University of Chicago $157,572 on July 1, 2026, under the Aging Research program (CFDA 93.866) to develop precision dosing models for androgen receptor signaling inhibitors in metastatic prostate cancer affecting older adults. The award funds research to validate the relationship between ARSI dose intensity and wearable sensor-derived metrics—particularly daily step counts—and their...
- The National Institute on Aging awarded Northwestern University $697,845 under the Aging Research program (CFDA 93.866) on September 20, 2025, to develop and deliver M4: Modules on Advanced Methodology When Modeling Multinational Data, a module-based training program in large-scale data analysis for researchers working with the Health and Retirement Study and the Harmonized Cognitive Assessment Protocol. The program equips early-career researchers with methodological skills to analyze...
- The National Institute on Aging awarded Wake Forest University Health Sciences $633,510 on September 1, 2026, under the Aging Research program (CFDA 93.866) to examine the impact of home-based medical care and telemedicine use on dementia care outcomes among Medicare enrollees with Alzheimer's disease and related dementias. The project will study home-based medical care delivery—house calls by physicians and advanced care providers—and telemedicine use among persons living with Alzheimer's...
- The National Institute on Aging, a component of the Department of Health and Human Services, awarded $834,775 to the Regents of the University of California, San Francisco on August 15, 2026, under the Aging Research program (CFDA 93.866) to conduct research identifying drivers of hospice disparities for older adults with and without Alzheimer's disease and related dementias (ADRD). The research examines regional hospice market variation as a structural factor driving disparities in hospice...
The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute rehabilitation at Medicare rates exceeding acute care hospital payments—against lower-cost skilled nursing facility (SNF) care. The study addresses methodological gaps in prior literature regarding whether Medicare patients achieve better outcomes with more expensive IRF treatment relative to SNF treatment, with outcomes analysis stratified by ADRD status. The research responds to rapid growth in the IRF sector, including 7.4 percent growth in freestanding IRFs and expanding for-profit ownership between 2022 and 2023, and informs potential site-neutral payment policy across post-acute care. The award carries a period of performance from September 1, 2026, through June 30, 2031, with work performed in Chicago, Illinois. The Aging Research program supports biomedical, social, and behavioral research directed toward understanding aging processes and diseases affecting older populations, with particular emphasis on Alzheimer's disease and related dementias.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $597.2k | 8/25/26 |